by James Edward Katz, M.D. | Nov 9, 2013 | Age Management, Cancer, Disease, Health Supplements, Hormone Supplementation Therapy, Preventative Medicine
The WHI (now over a decade old) remains the largest randomly controlled trial of women’s hormonal medicines. The original publication of WHI identified increased risks of breast cancer, stroke, and cardiovascular disease associated with hormone therapy. These findings...
by James Edward Katz, M.D. | Nov 9, 2013 | Age Management, Aging, Cancer, Dementia, Disease, Medications, Preventative Medicine
The M. D. Anderson Hospital reported that Celebrex, an arthritis medication, reduced precancerous markers in smokers. Sloan-Kettering Hospital in New York confirmed similar results. Neither study was structured to see if Celebrex reduced lung tumors (that takes 10+...
